Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 30, 2003. The report details a specific corporate action regarding share repurchases authorized by shareholders at the Annual General Meeting on May 19, 2003.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to a specific share buyback transaction:
- Shares Purchased: 795,000 ordinary shares
- Price per Share: 1,257.42p
- Purpose: Cancellation
Material Changes
The filing reports a reduction in the company's outstanding share count due to the purchase and cancellation of 795,000 shares. No other material changes to operations or financial position are disclosed in this specific document.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, contingencies, or discussion of unusual items beyond the execution of the authorized share repurchase.
Investor Verification Points
- Verify the total number of shares repurchased and cancelled to date under the May 2003 authorization.
- Confirm the total capital expenditure for this specific tranche of buybacks (795,000 shares at 1,257.42p).
- Review the company's full annual or interim financial reports for comprehensive revenue and profit data, as this Form 6-K is limited to the share transaction.